Related Experiment Video
Updated: Jan 11, 2026
07:49
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
3.1K
Mitochondria-targeted strategies in tumor immunity
Xudong Cheng1,2, Yian Wang2, Bryon Johnson3
1Department of Pharmacy, Suzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
Frontiers in Immunology
|November 17, 2025
Summary
Mitochondria influence tumor immunity by altering the tumor microenvironment and immune cell function. Targeting mitochondria offers a strategy to reduce immunosuppression and enhance anti-tumor responses for novel cancer therapies.
Area of Science:
- * Mitochondrial biology and cancer immunology.
- * Cellular metabolism and tumor microenvironment.
- * Immunotherapy and targeted drug delivery.
Background:
- * Mitochondria regulate cellular energy and metabolism, impacting tumor growth.
- * Tumor reprogramming (Warburg effect) alters microenvironment pH, affecting immune cells.
- * Mitochondrial reactive oxygen species (ROS) and damage-associated molecular patterns (DAMPs) modulate immune responses.
Purpose of the Study:
- * To review the multifaceted role of mitochondria in tumor immunity.
- * To discuss strategies for targeting tumor cell mitochondria.
- * To highlight advancements in mitochondria-targeted drugs for cancer therapy.
Main Methods:
- * Literature review of mitochondrial function in cancer immunity.
- * Analysis of metabolic reprogramming and its immunomodulatory effects.
- * Examination of drug delivery systems targeting mitochondria.
Main Results:
- * Mitochondrial metabolic shifts create an immunosuppressive tumor microenvironment.
- * Mitochondria influence immune cell function through ROS and DAMPs.
- * Targeted delivery strategies can enhance drug penetration into mitochondria.
Conclusions:
- * Mitochondria are key regulators of the tumor immune landscape.
- * Targeting tumor mitochondria presents a promising avenue for cancer immunotherapy.
- * Development of mitochondria-targeted drugs can overcome immunosuppression and boost anti-tumor immunity.
Related Concept Videos
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:46Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K